首页> 外文期刊>Regulatory peptides. >Effect of exendin-4 treatment upon glucose uptake parameters in rat liver and muscle, in normal and type 2 diabetic state.
【24h】

Effect of exendin-4 treatment upon glucose uptake parameters in rat liver and muscle, in normal and type 2 diabetic state.

机译:在正常和2型糖尿病状态下,exendin-4处理对大鼠肝脏和肌肉葡萄糖摄取参数的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Exendin-4, like GLP-1, is insulinotropic, antidiabetic and glucoregulatory among other properties, which are thought to be exerted through the pancreatic GLP-1 receptor; exendin-4 is also an agonist of the GLP-1 stimulatory action upon liver and muscle glucose metabolism, where GLP-1 receptor is distinct from that in the pancreas. We investigated the action of prolonged treatment with exendin-4 upon glucose transport parameters in skeletal muscle and liver of normal rats and streptozotocin-induced type 2 diabetic rats (T2D). Muscle of T2D showed lower than normal glucose transport; exendin-4 did not modify the value in normal but normalized that in the T2D; unlike previously detected with GLP-1, no apparent modification was observed in GLUT-4 expression in either group after exendin-4, except for an increased GLUT-4 protein in normal rats. Yet, exendin-4 significantly stimulated liver GLUT-2-mRNA and -protein in T2D and normal rats, the effect upon GLUT-2-protein in T2D being higher than that in normalanimals; this was accompanied by a normalizing action of exendin-4 upon the lower than normal liver glycogen in T2D rats. These data suggest that the liver may represent at least one of the major target organs for exendin-4 to exert its plasma lowering effect in diabetic state.
机译:像GLP-1一样,Exendin-4具有促胰岛素,抗糖尿病和糖调节的特性,被认为是通过胰腺GLP-1受体发挥作用的。 exendin-4还是GLP-1对肝脏和肌肉葡萄糖代谢的刺激作用的激动剂,其中GLP-1受体与胰腺中的受体不同。我们研究了用exendin-4延长治疗对正常大鼠和链脲佐菌素诱导的2型糖尿病大鼠(T2D)骨骼肌和肝脏中葡萄糖转运参数的作用。 T2D肌肉显示低于正常的葡萄糖转运。 exendin-4正常时未修改该值,但在T2D中将其标准化。与以前用GLP-1检测到的不同,在exendin-4之后,两组中的GLUT-4表达均未见明显改变,除了正常大鼠中GLUT-4蛋白增加外。然而,exendin-4显着刺激了T2D和正常大鼠的肝脏GLUT-2-mRNA和-蛋白,对T2D的GLUT-2-蛋白的作用高于正常动物。这伴随着exendin-4对T2D大鼠肝糖原水平低于正常水平的正常作用。这些数据表明,肝脏可能代表exendin-4的至少一个主要靶器官,在糖尿病状态下发挥血浆降低作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号